Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Nuformix plc (NFX) Ordinary 0.1p Shares

Sell:3.80p Buy:4.00p 0 Change: 0.04p (1.04%)
Market closed Prices as at close on 12 August 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:3.80p
Buy:4.00p
Change: 0.04p (1.04%)
Market closed Prices as at close on 12 August 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:3.80p
Buy:4.00p
Change: 0.04p (1.04%)
Market closed Prices as at close on 12 August 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Nuformix PLC, formerly Levrett PLC, is a United Kingdom-based pharmaceutical development company. The Company uses cocrystal technology to develop drugs with programs in oncology supportive care and fibrosis. It uses cocrystal technology to re-engineer the crystalline form of drugs. Its clinical pipeline includes NXP001 and NXP002. Its pre-clinical pipeline includes NXP003. It is developing NXP001 for oncology supportive care. It is developing NXP002 for the treatment of multiple fibrotic diseases. NXP003 targets a mechanism understood to confer resistance to immuno-oncology, chemotherapy and radiotherapy cancer treatments.

Contact details

Address:
153 Science Park, Milton Road
CAMBRIDGE
CB4 0GN
United Kingdom
Telephone:
+ (0)
Website:
https://nuformix.com/

Important dates

Future events
AGM 20 August 2020 20/08/20
Past events
Annual report 28 July 2020 28/07/20
Final results 22 July 2020 22/07/20
Interim results 24 December 2019 24/12/19
AGM 10 September 2019 10/09/19

General stock information

EPIC:
NFX
ISIN:
GB00BYW79Y38
Market cap:
£19.12 million
Shares in issue:
490.15 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.